Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Kaia Health, a digital therapeutics company based in Munich, Germany, has raised $10 million in a Series A funding round for its apps that use AI and motion-tracking technology to manage chronic back pain and chronic obstructive pulmonary disease (COPD), according to a report by VentureBeat.
The HHS Office of the Chief Technology Office and President Innovation Fellows have completed a 14-week tech challenge that encouraged teams to create digital tools using federal data and emerging technologies—like AI—to help address several challenges in healthcare.
The FDA is fast-tracking efforts to produce an over-the-counter version of naloxone, a life-saving drug which can reverse an opioid overdose. Current FDA-approved versions of naloxone require a prescription, creating a barrier of use for some.
Healthcare, senior care and mental health diagnosis and treatment are among several industries expected to be “revolutionized” by AI, according to a report by Forbes.
A professor at Virginia Tech is gearing up for a four-year study that will use machine-learning techniques to help physicians decrease the number of deaths from traumatic brain injuries (TBIs).
Walgreens Boots Alliance (WBA) has teamed up with technology company Microsoft to develop new healthcare delivery models, the companies announced Jan. 15.
A University of Vermont-led research team combined wearable and AI technology to quickly and accurately detect internalizing disorders, like anxiety and depression, in young children, according to a study published in PLOS One.
